| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |